↓ Skip to main content

Dove Medical Press

Clinical utility of ramucirumab in non-small-cell lung cancer

Overview of attention for article published in Biologics: Targets & Therapy, July 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users
facebook
2 Facebook pages
reddit
1 Redditor

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
32 Mendeley
Title
Clinical utility of ramucirumab in non-small-cell lung cancer
Published in
Biologics: Targets & Therapy, July 2019
DOI 10.2147/btt.s175034
Pubmed ID
Authors

Dipesh Uprety

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 16%
Student > Master 4 13%
Student > Ph. D. Student 3 9%
Student > Doctoral Student 2 6%
Student > Bachelor 2 6%
Other 2 6%
Unknown 14 44%
Readers by discipline Count As %
Medicine and Dentistry 8 25%
Biochemistry, Genetics and Molecular Biology 4 13%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Business, Management and Accounting 1 3%
Mathematics 1 3%
Other 2 6%
Unknown 14 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 August 2019.
All research outputs
#16,053,755
of 25,385,509 outputs
Outputs from Biologics: Targets & Therapy
#176
of 284 outputs
Outputs of similar age
#207,010
of 363,724 outputs
Outputs of similar age from Biologics: Targets & Therapy
#3
of 3 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,724 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.